These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 180198)

  • 1. Adenine arabinoside for therapy of herpes zoster in immunosuppressed patients: preliminary results of a collaborative study.
    Ch'ien LT; Whitley RJ; Alford CA; Galasso GJ
    J Infect Dis; 1976 Jun; 133 Suppl():A184-91. PubMed ID: 180198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study.
    Whitley RJ; Ch'ien LT; Dolin R; Galasso GJ; Alford CA
    N Engl J Med; 1976 May; 294(22):1193-9. PubMed ID: 177866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: Efficacy of adenine arabinoside in herpes zoster.
    Merigan TC
    N Engl J Med; 1976 May; 294(22):1233-4. PubMed ID: 772429
    [No Abstract]   [Full Text] [Related]  

  • 4. Early vidarabine therapy to control the complications of herpes zoster in immunosuppressed patients.
    Whitley RJ; Soong SJ; Dolin R; Betts R; Linnemann C; Alford CA
    N Engl J Med; 1982 Oct; 307(16):971-5. PubMed ID: 7110300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adenine arabinoside treatment of varicella and generalized herpes zoster in 43 immunosuppressed patients].
    Vildé JL; Bricaire F; Huchon A; Dournon E; Brun-Vezinet F; Leport C; Bastin R
    Nouv Presse Med; 1982 Nov; 11(48):3547-50. PubMed ID: 7155866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of varicella-zoster virus infections with adenine arabinoside.
    Johnson MT; Buchanan RA; Luby JP; Mikulec D
    J Infect Dis; 1975 Mar; 131(3):225-9. PubMed ID: 165242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disseminated herpes zoster in the immunocompromised host: a comparative trial of acyclovir and vidarabine. The NIAID Collaborative Antiviral Study Group.
    Whitley RJ; Gnann JW; Hinthorn D; Liu C; Pollard RB; Hayden F; Mertz GJ; Oxman M; Soong SJ
    J Infect Dis; 1992 Mar; 165(3):450-5. PubMed ID: 1538151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative use of adenine arabinoside and adenine arabinoside monophosphate in varicella and disseminated zoster in immunosuppressed patients.
    Vilde JL; Bricaire F; Huchon A; Brun-Vezinet F
    J Med Virol; 1983; 12(2):149-53. PubMed ID: 6194253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective double-blind evaluation of topical adenine arabinoside in male herpes progenitalis.
    Goodman EL; Luby JP; Johnson MT
    Antimicrob Agents Chemother; 1975 Dec; 8(6):693-7. PubMed ID: 174489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double blind trial in the treatment of herpes simplex and herpes zoster with adenine arabinoside and idoxuridine.
    Theodoridis A; Sivenas C; Vagena A; Capetanakis J
    Arch Dermatol Res; 1978 Jul; 262(2):173-6. PubMed ID: 356754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genital herpetic infection in men and women: clinical course and effect of topical application of adenine arabinoside.
    Adams HG; Benson EA; Alexander ER; Vontver LA; Remington MA; Holmes KK
    J Infect Dis; 1976 Jun; 133 Suppl():A151-9. PubMed ID: 180196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2'-Fluoro-5-iodoarabinosylcytosine, a new potent antiviral agent: efficacy in immunosuppressed individuals with herpes zoster.
    Leyland-Jones B; Donnelly H; Groshen S; Myskowski P; Donner AL; Fanucchi M; Fox J
    J Infect Dis; 1986 Sep; 154(3):430-6. PubMed ID: 3525694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity of adenine arabinoside in humans.
    Ross AH; Julia A; Balakrishnan C
    J Infect Dis; 1976 Jun; 133 Suppl():A192-8. PubMed ID: 180199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of adenine arabinoside and trifluorothymidine in the treatment of corneal ulcers caused by herpes simplex virus.
    Coster DJ; McKinnon JR; McGill JI; Jones BR; Fraunfelder FT
    J Infect Dis; 1976 Jun; 133 Suppl():A173-7. PubMed ID: 819598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous adenine arabinoside against herpes simplex keratouveitis in humans.
    Abel R; Kaufman HE; Sugar J
    Am J Ophthalmol; 1975 Apr; 79(4):659-64. PubMed ID: 1091151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental herpes simplex virus encephalitis: Comparative effects of treatment with cytosine arabinoside and adenine arabinoside.
    Griffith JF; Fitzwilliam JF; Casagrande S; Butler SR
    J Infect Dis; 1975 Nov; 132(5):506-10. PubMed ID: 171318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenine arabinoside in the management of herpetic keratitis.
    McGill JI; Coster D; Frauenfelder T; Holt-Wilson AD; Williams H; Jones BR
    Trans Ophthalmol Soc U K (1962); 1975 Jul; 95(2):246-9. PubMed ID: 818752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse effect of cytosine arabinoside on disseminated zoster in a controlled trial.
    Stevens DA; Jordan GW; Waddell TF; Merigan TC
    N Engl J Med; 1973 Oct; 289(17):873-8. PubMed ID: 4354007
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytosine arabinoside for localized herpes zoster in patients with cancer: failure in a controlled trial.
    Schimpff SC; Fortner CL; Greene WH; Wiernik PH
    J Infect Dis; 1974 Dec; 130(6):673-6. PubMed ID: 4372276
    [No Abstract]   [Full Text] [Related]  

  • 20. Ineffectiveness of subcutaneous cytosine arabinoside in localized herpes zoster.
    Betts RF; Zaky DA; Douglas RG; Royer G
    Ann Intern Med; 1975 Jun; 82(6):778-83. PubMed ID: 166586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.